Cargando…
Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice
The present study investigated the effect and underlying mechanisms of ginsenoside Rg1 (Rg1) in attenuating subacute liver injury induced by D-galactose (D-gal) in mice. Specific Pathogen Free (SPF) male C57BL/6J mice were randomly divided into 3 groups: i) D-gal-administration group (D-gal group),...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200997/ https://www.ncbi.nlm.nih.gov/pubmed/30402153 http://dx.doi.org/10.3892/etm.2018.6727 |
_version_ | 1783365433075695616 |
---|---|
author | Xiao, Ming-He Xia, Jie-Yu Wang, Zi-Ling Hu, Wen-Xu Fan, Yan-Ling Jia, Dao-Yong Li, Jing Jing, Peng-Wei Wang, Lu Wang, Ya-Ping |
author_facet | Xiao, Ming-He Xia, Jie-Yu Wang, Zi-Ling Hu, Wen-Xu Fan, Yan-Ling Jia, Dao-Yong Li, Jing Jing, Peng-Wei Wang, Lu Wang, Ya-Ping |
author_sort | Xiao, Ming-He |
collection | PubMed |
description | The present study investigated the effect and underlying mechanisms of ginsenoside Rg1 (Rg1) in attenuating subacute liver injury induced by D-galactose (D-gal) in mice. Specific Pathogen Free (SPF) male C57BL/6J mice were randomly divided into 3 groups: i) D-gal-administration group (D-gal group), where the mice were intraperitoneally administrated with D-gal (120 mg/kg/day for 42 days); ii) D-gal + Rg1 group where the mice were treated with 120 mg/kg/day D-gal for 42 days and with Rg1 at a dose of 20 mg/kg/day for 35 days. The first dose of Rg1 was administered on the 8th day of treatment with D-gal; and iii) the normal control group, where the mice were injected with an equal volume of saline for 42 days. The day following the final injections in all groups, peripheral blood was collected and serum was prepared to measure the contents of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (TBiL), advanced glycation end products (AGEs) and 8-hydroxy-2 deoxyguanosine (8-OH-dG). Liver tissue homogenates were prepared to measure the contents of malondialdehyde (MDA) and glutathione (GSH), and the activities of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD). Paraffin section were prepared to observe the microscopic structure of the liver. Transmission electron microscopy was used to observe the ultrastructure of hepatocytes. Frozen section were prepared and stained with senescence-associated β-galactosidase to detect the relative optical density value of senescence-associated markers. Compared with the D-gal group, the contents of AST, ALT, TBiL, AGEs and MDA significantly decreased in the D-gal + Rg1 group, while the activities of SOD and GSH-Px markedly increased, and liver injury and degenerative alterations of hepatocytes were reduced. Administration of Rg1 induced a protective effect on D-gal-induced liver injury in mice by inhibiting the oxidative stress, reducing DNA damage and decreasing the AGE content. |
format | Online Article Text |
id | pubmed-6200997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-62009972018-11-06 Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice Xiao, Ming-He Xia, Jie-Yu Wang, Zi-Ling Hu, Wen-Xu Fan, Yan-Ling Jia, Dao-Yong Li, Jing Jing, Peng-Wei Wang, Lu Wang, Ya-Ping Exp Ther Med Articles The present study investigated the effect and underlying mechanisms of ginsenoside Rg1 (Rg1) in attenuating subacute liver injury induced by D-galactose (D-gal) in mice. Specific Pathogen Free (SPF) male C57BL/6J mice were randomly divided into 3 groups: i) D-gal-administration group (D-gal group), where the mice were intraperitoneally administrated with D-gal (120 mg/kg/day for 42 days); ii) D-gal + Rg1 group where the mice were treated with 120 mg/kg/day D-gal for 42 days and with Rg1 at a dose of 20 mg/kg/day for 35 days. The first dose of Rg1 was administered on the 8th day of treatment with D-gal; and iii) the normal control group, where the mice were injected with an equal volume of saline for 42 days. The day following the final injections in all groups, peripheral blood was collected and serum was prepared to measure the contents of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (TBiL), advanced glycation end products (AGEs) and 8-hydroxy-2 deoxyguanosine (8-OH-dG). Liver tissue homogenates were prepared to measure the contents of malondialdehyde (MDA) and glutathione (GSH), and the activities of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD). Paraffin section were prepared to observe the microscopic structure of the liver. Transmission electron microscopy was used to observe the ultrastructure of hepatocytes. Frozen section were prepared and stained with senescence-associated β-galactosidase to detect the relative optical density value of senescence-associated markers. Compared with the D-gal group, the contents of AST, ALT, TBiL, AGEs and MDA significantly decreased in the D-gal + Rg1 group, while the activities of SOD and GSH-Px markedly increased, and liver injury and degenerative alterations of hepatocytes were reduced. Administration of Rg1 induced a protective effect on D-gal-induced liver injury in mice by inhibiting the oxidative stress, reducing DNA damage and decreasing the AGE content. D.A. Spandidos 2018-11 2018-09-11 /pmc/articles/PMC6200997/ /pubmed/30402153 http://dx.doi.org/10.3892/etm.2018.6727 Text en Copyright: © Xiao et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Xiao, Ming-He Xia, Jie-Yu Wang, Zi-Ling Hu, Wen-Xu Fan, Yan-Ling Jia, Dao-Yong Li, Jing Jing, Peng-Wei Wang, Lu Wang, Ya-Ping Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice |
title | Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice |
title_full | Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice |
title_fullStr | Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice |
title_full_unstemmed | Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice |
title_short | Ginsenoside Rg1 attenuates liver injury induced by D-galactose in mice |
title_sort | ginsenoside rg1 attenuates liver injury induced by d-galactose in mice |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200997/ https://www.ncbi.nlm.nih.gov/pubmed/30402153 http://dx.doi.org/10.3892/etm.2018.6727 |
work_keys_str_mv | AT xiaominghe ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice AT xiajieyu ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice AT wangziling ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice AT huwenxu ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice AT fanyanling ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice AT jiadaoyong ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice AT lijing ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice AT jingpengwei ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice AT wanglu ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice AT wangyaping ginsenosiderg1attenuatesliverinjuryinducedbydgalactoseinmice |